100 related articles for article (PubMed ID: 1697642)
1. Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.
Missale G; Missale C; Sigala S; Cestari R; Memo M; Lojacono L; Spano P
Life Sci; 1990; 47(5):447-55. PubMed ID: 1697642
[TBL] [Abstract][Full Text] [Related]
2. Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries.
Missale C; Pizzi M; Memo M; Picotti GB; Carruba MO; Spano PF
Neurosci Lett; 1985 Oct; 61(1-2):207-11. PubMed ID: 2867503
[TBL] [Abstract][Full Text] [Related]
3. Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.
Sigala S; Missale G; Raddino R; Cestari R; Lojacono L; Missale C; Spano PF
Life Sci; 1994; 54(15):1035-45. PubMed ID: 7908711
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
5. Adenylate cyclase from sea urchin eggs is positively and negatively regulated by D-1 and D-2 dopamine receptors.
Carginale V; Capasso A; Madonna L; Borrelli L; Parisi E
Exp Cell Res; 1992 Dec; 203(2):491-4. PubMed ID: 1360904
[TBL] [Abstract][Full Text] [Related]
6. Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
Sigala S; Rizzonelli P; Zanelli E; Forgione A; Missale C; Spano P
Eur J Pharmacol; 1991 Jun; 199(2):247-53. PubMed ID: 1683290
[TBL] [Abstract][Full Text] [Related]
7. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
9. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of fenoldopam.
Nichols AJ; Ruffolo RR; Brooks DP
Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
[TBL] [Abstract][Full Text] [Related]
11. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
12. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
Grenader A; Healy DP
J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
[TBL] [Abstract][Full Text] [Related]
13. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat.
Kinoshita S; Sidhu A; Felder RA
J Clin Invest; 1989 Dec; 84(6):1849-56. PubMed ID: 2574187
[TBL] [Abstract][Full Text] [Related]
14. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
15. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi M; Caron MG
J Biol Chem; 1994 Nov; 269(45):27925-31. PubMed ID: 7525564
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus.
Grilli M; Nisoli E; Memo M; Missale C; Spano PF
Neurosci Lett; 1988 May; 87(3):253-8. PubMed ID: 2898118
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
[TBL] [Abstract][Full Text] [Related]
18. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
[TBL] [Abstract][Full Text] [Related]
19. Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Schrell UM; Fahlbusch R; Adams EF; Nomikos P; Reif M
J Clin Endocrinol Metab; 1990 Dec; 71(6):1669-71. PubMed ID: 1699967
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
